ArticleMolecular therapy. Nucleic acids2025
DRPM: An advanced predictive model for early diabetes detection and risk stratification.
Article in Molecular therapy. Nucleic acids, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes is a prevalent chronic disease that poses a significant burden on individuals and healthcare systems. Early diagnosis and effective management are essential for delaying disease onset and minimizing complications. In this study, we developed a deep learning-based risk prediction model using data from the National Health and Nutrition Examination Survey (NHANES) spanning from 2011 to 2018. From an initial set of 36 variables, and through feature selection, five key features were identified through feature selection techniques to construct the model. The model demonstrated robust performance, accurately predicting diabetes risk with high precision in test data. External validation further confirmed its ability to correctly identify individuals at risk of developing diabetes. To enhance its practical application, we implemented a risk stratification system and developed a user-friendly online tool, available at http://cbcb.cdutcm.edu.cn/drpm/, allowing easy access for users. This model provides a valuable tool for diabetes risk screening and personalized early detection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.